Document is current

Any future updates will be listed below

LINC00162 silencing enhances sorafenib sensitivity and inhibits thyroid cancer cells progression through modulation of MAPK signaling and apoptosis

Crossref DOI link: https://doi.org/10.1038/s41598-025-12805-x

Published Online: 2025-08-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark